BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Bromocriptine

A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion.

299+ PubMed studies analyzed · 31 RCTs · Evidence Score: 51

Research Domains

Bromocriptine has been studied across 17 research domains including 🧠 Focus & Attention, 🌤️ Mood & Depression, 🧬 Hormones, 🔬 Oncology, 🧠 Neuroprotection. The primary research focus is 🧠 Focus & Attention with 32% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Bromocriptine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Lisuride
30 shared targets
Yohimbine
29 shared targets
Dihydroergotamine
31 shared targets
Pergolide
27 shared targets
Ergotamine
24 shared targets
Amoxapine
37 shared targets
Quetiapine
27 shared targets
Oxymetazoline
20 shared targets
Buspirone
25 shared targets
Mianserin
28 shared targets
Loading evidence profile...

This evidence profile for Bromocriptine is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.